Wednesday, October 3, 2012

Warrior Forum Review ; About Internet Warrior Forum |

Many marketing programs that we have reviewed often suggest a place to join and ?hang out? is the Warrior Forum or Internet Marketing Forums.

The one we have heard most about is www.warriorforum.com.

The idea is to become a frequent member, and offer some helpful comments on different questions people may have, then as YOUR name becomes seen and TRUSTED as an authority on some online marketing subject, others will tend to follow you to your program.

Now, if you are brand new and feel you have nothing to offer, then how will this work for you to get traffic?

Well, it may not work that great.

So, we are not knocking this idea of hanging w/ the other ?successful marketers? at this or other forums, but it can be tough trying to get a following when we have minimal skills to offer.

Also, we have been online since around 2004, and we never had reason to join the forum or to use it to get traffic.

We were VERY lucky to have found a trustworthy guy that showed us some REAL traffic generating methods that still work today some 8 years later.

The reason they work is because they are based on the simple foundation that the whole internet is based on?.people searching for specific information or KEYWORDS, then offering them the EXACT info they were looking for.

The worst thing to deal with online is searching for something then finding every WRONG website in the whole internet instead of a simple site that offers simple answers.

Are you following this simple thought?

One thing we tell all new members of our top program is MOST programs DO WORK.

The problem is too many people do not learn traffic and do not work hard enough to grow the traffic that they decide to build. A couple classified ads posted once a week will get you near ZERO results for example.

This is one traffic method we start people with because it is easy to COPY?all you need to do is COPY and PASTE an ad we give you then send the ad. You won?t get a flood of traffic from one ad?but you will get opt ins and you will eventually get a sale.

==>> List Building Review

We hope this was helpful. Keep in mind there are millions of new people each day looking for a way to earn online, so there will be many at these forums that could use some help even if you know very little?so don?t hesitate to check them out, especially the Warrior Forum as they are one of the most legit and long standing sites around.

Click Here To Get FR.EE Info on Our Top Rated Program Hope to see you soon!!

Source: http://income.businessreviews4you.com/warrior-forum-review-internet-warrior-forum-truth/

megamillions drawing olbermann mega millions march 30 lucky numbers odds of winning mega millions mary mary sag aftra merger

Tuesday, October 2, 2012

Video: Speed Limit for High Frequency Trading?

Sorry, Readability was unable to parse this page for content.

Source: http://video.msnbc.msn.com/cnbc/49262858/

rashard lewis curacao curacao home run derby kourtney kardashian kourtney kardashian DNS Changer

Nest 2.0: The Smart Thermostat Is Thinner, Works With More Home Heating Systems Than Before [Nest]

Nest was not the first smart thermostat to reach the hands of consumers. But it was the first that made our parents (and maybe even some of our grandparents) raise an eyebrow. Its cylindrical form and simple GUI are nothing, if not inviting to use, and its ability to learn from your usage habits not only offers convenience, but possible savings when it comes to the power bill. Now with the second generation iteration of Nest—one that is slimmer and guaranteed to work with 95% of home heating systems—the product wants to go from being a buzzy new product to a mainstream, must-have home gadget. More »


Source: http://feeds.gawker.com/~r/gizmodo/full/~3/3bwYaUUWCqw/nest-20-the-smart-thermostat-is-thinner-works-with-more-home-heating-systems-than-before

scarlett o hara pat sajak vanna white michael robinson joe paterno memorial service taco bell breakfast menu ener1

2 Comments - thequestionclub:

If you wear contacts, where do you have your eye exams done/where do you buy your contacts? Do you live somewhere where you're required to have yearly eye exams in order to buy contacts??

I usually go to Wal-Mart's vision center, but I moved and there's not one near me and I need a new place. Indiana requires yearly exams for contacts and exams every two years to buy new glasses. It's lame, especially for someone who doesn't have eye insurance or whatever you call it.

Source: http://thequestionclub.livejournal.com/110257475.html

death race buffet rule carlos santana baa dodgers triple play samoyed kenny powers

Monday, October 1, 2012

Patient-led advocacy has changed how US government funds medical research

Patient-led advocacy has changed how US government funds medical research [ Back to EurekAlert! ] Public release date: 1-Oct-2012
[ | E-mail | Share Share ]

Contact: Daniel Fowler
pubinfo@asanet.org
202-527-7885
American Sociological Association

WASHINGTON, DC, September 27, 2012 Patient-led advocacy has created a shift in the way the U.S. government has prioritized funding for medical research, and significantly changed the way policymakers think about who benefits the most from these dollars, a University of Michigan School of Public Health fellow in the Robert Wood Johnson Foundation Scholars in Health Policy Research Program found.

In "Disease Politics and Medical Research Funding: Three Ways Advocacy Shapes Policy," a paper published in the October issue of the American Sociological Review, Rachel Kahn Best analyzed data on 53 diseases over a 19-year period from 1989-2007.

She found that those diseases tied to strong advocacy organizations received millions of dollars more in research funding over the period than others whose advocates were not as strong. She also found an increasing number of these organizations, from about 400 large nonprofits working on disease advocacy in the early 1990s to more than 1,000 by 2003.

In addition, Best noted another fundamental shift in policy brought about by advocacy. Where policymakers once focused on providing dollars to the scientists who made the best case for fundingwith the general population thought of as the beneficiaries of their researchthe government began to think of patients with particular diseases as the recipients of the research funds. This resulted in funding based on "perceived moral worthiness."

"The downside is not every disease has this potential for strong advocacy," Best said. "In addition to things like lung cancer and liver disease, which lose out because of the social stigma tied to those diagnoses, there are diseases like pancreatic cancer, whose patients often don't live very long after diagnosis and, therefore, don't have time to tell their stories.

"In the years I studied, the National Institutes of Health budget was expanding rapidly. But in more recent years, we've seen a leveling off of what funding is available. It will be interesting to see if, after the time period I studied, disease advocates have become more competitive in their efforts to secure a share of the dollars."

Best also found that advocacy groups created political pressure to have funding allocated in line with mortality rates. After activists mobilized against an initially weak response to AIDS, it eventually received more research funding than any other disease.

Subsequently, advocates for other diseases protested that they were receiving fewer "dollars per death." Policymakers then pressured the NIH to bring the funding distribution more in line with mortality, even though NIH officials preferred to set priorities based on scientific criteria.

To reach her conclusions, Best collected data from the NIH and the Department of DefenseCongressionally Directed Medical Research Programs to determine dollars spent on various diseases. She gathered tax data on disease-related nonprofits and collected data on congressional hearings at which disease advocates gave testimony. She also reviewed mortality data for the 53 diseases that ranged from various cancers and influenza to hypertension and diabetes.

###

About the American Sociological Association and the American Sociological Review

The American Sociological Association (www.asanet.org), founded in 1905, is a non-profit membership association dedicated to serving sociologists in their work, advancing sociology as a science and profession, and promoting the contributions to and use of sociology by society. The American Sociological Review is the ASA's flagship journal.

The research article described above is available by request for members of the media. For a copy of the full study, contact Daniel Fowler, ASA's Media Relations and Public Affairs Officer, at (202) 527-7885 or pubinfo@asanet.org.

For more information about the study, members of the media can also contact Laurel Thomas Gnagey, University of Michigan, at (734) 647-1841 or ltgnagey@umich.edu.



[ Back to EurekAlert! ] [ | E-mail | Share Share ]

?


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


Patient-led advocacy has changed how US government funds medical research [ Back to EurekAlert! ] Public release date: 1-Oct-2012
[ | E-mail | Share Share ]

Contact: Daniel Fowler
pubinfo@asanet.org
202-527-7885
American Sociological Association

WASHINGTON, DC, September 27, 2012 Patient-led advocacy has created a shift in the way the U.S. government has prioritized funding for medical research, and significantly changed the way policymakers think about who benefits the most from these dollars, a University of Michigan School of Public Health fellow in the Robert Wood Johnson Foundation Scholars in Health Policy Research Program found.

In "Disease Politics and Medical Research Funding: Three Ways Advocacy Shapes Policy," a paper published in the October issue of the American Sociological Review, Rachel Kahn Best analyzed data on 53 diseases over a 19-year period from 1989-2007.

She found that those diseases tied to strong advocacy organizations received millions of dollars more in research funding over the period than others whose advocates were not as strong. She also found an increasing number of these organizations, from about 400 large nonprofits working on disease advocacy in the early 1990s to more than 1,000 by 2003.

In addition, Best noted another fundamental shift in policy brought about by advocacy. Where policymakers once focused on providing dollars to the scientists who made the best case for fundingwith the general population thought of as the beneficiaries of their researchthe government began to think of patients with particular diseases as the recipients of the research funds. This resulted in funding based on "perceived moral worthiness."

"The downside is not every disease has this potential for strong advocacy," Best said. "In addition to things like lung cancer and liver disease, which lose out because of the social stigma tied to those diagnoses, there are diseases like pancreatic cancer, whose patients often don't live very long after diagnosis and, therefore, don't have time to tell their stories.

"In the years I studied, the National Institutes of Health budget was expanding rapidly. But in more recent years, we've seen a leveling off of what funding is available. It will be interesting to see if, after the time period I studied, disease advocates have become more competitive in their efforts to secure a share of the dollars."

Best also found that advocacy groups created political pressure to have funding allocated in line with mortality rates. After activists mobilized against an initially weak response to AIDS, it eventually received more research funding than any other disease.

Subsequently, advocates for other diseases protested that they were receiving fewer "dollars per death." Policymakers then pressured the NIH to bring the funding distribution more in line with mortality, even though NIH officials preferred to set priorities based on scientific criteria.

To reach her conclusions, Best collected data from the NIH and the Department of DefenseCongressionally Directed Medical Research Programs to determine dollars spent on various diseases. She gathered tax data on disease-related nonprofits and collected data on congressional hearings at which disease advocates gave testimony. She also reviewed mortality data for the 53 diseases that ranged from various cancers and influenza to hypertension and diabetes.

###

About the American Sociological Association and the American Sociological Review

The American Sociological Association (www.asanet.org), founded in 1905, is a non-profit membership association dedicated to serving sociologists in their work, advancing sociology as a science and profession, and promoting the contributions to and use of sociology by society. The American Sociological Review is the ASA's flagship journal.

The research article described above is available by request for members of the media. For a copy of the full study, contact Daniel Fowler, ASA's Media Relations and Public Affairs Officer, at (202) 527-7885 or pubinfo@asanet.org.

For more information about the study, members of the media can also contact Laurel Thomas Gnagey, University of Michigan, at (734) 647-1841 or ltgnagey@umich.edu.



[ Back to EurekAlert! ] [ | E-mail | Share Share ]

?


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


Source: http://www.eurekalert.org/pub_releases/2012-10/asa-pah092712.php

Bourne Legacy Chad Johnson London 2012 Soccer dwight howard Olympics closing ceremony PGA Championship 2012 John Witherspoon

Orioles beat Boston, gain tie for AL East lead

BALTIMORE (AP) ? The Baltimore Orioles are tied atop the AL East with the New York Yankees with four games left, a scenario that might cause a team unaccustomed to being in a pennant race to stumble under pressure.

Not these guys.

After Baltimore beat the Boston Red Sox 4-3 Saturday night to earn a share of first place, Orioles first baseman Mark Reynolds described the mood of the team as "a quiet confidence."

"Calmness," Reynolds said. "We're playing with house money. We're not supposed to be here. We're just a bunch of kids having fun. We go out every night believing we're going to win the game, no matter what the situation and no matter who we're facing. It's just fun to be a part of."

Chris Davis hit his 30th home run and rookie Manny Machado lined a go-ahead shot in the seventh inning for the Orioles. After finishing in the division cellar in each of the previous four seasons, Baltimore (91-67) is tied with a team very much accustomed to finishing in first place.

The Yankees lost to Toronto before this game started, so the Orioles knew they would earn a share of the lead with a win. Baltimore went ahead 3-0 in the fourth, then let Boston pull even before Machado homered, a liner into the second row of the left-field seats off Felix Doubront (11-10).

Machado has been a major leaguer for all of 47 games after being summoned from Double-A Bowie on Aug. 9.

"I'm just trying to play the game," he said. "Obviously, it's bigger than any other games I've played before. I'm just going to try and go out there and give everything I can to help this team win."

It was another tight victory for the Orioles, their trademark in this unimaginable season. Baltimore is 28-9 in one-run games and 72-0 when leading after seven innings.

"It's an honor to sit there and watch it and marvel at what these guys can do, especially when certain things start snowballing," manager Buck Showalter said. "And you create your karma. These guys have done a good job of doing that, and they're expecting good things to happen."

Tommy Hunter (7-8) pitched two innings, Brian Matusz and Darren O'Day shared the eighth and Jim Johnson got three outs for his 49th save.

A sellout crowd of 46,311, a majority of them clad in Oriole orange, brought Camden Yards back to a time when the home team was a force in the AL East and the ballpark was packed on a nightly basis.

The fans got to cheer a Baltimore great before the first pitch, too. A statue of Hall of Fame third baseman Brooks Robinson was unveiled during a ceremony in the flag court beyond the center-field wall.

The Orioles' goal is to capture the division, but if they win two more games they are at least assured of their first trip to the playoffs since 1997 ? their last winning season before this year. Baltimore now is 41-27 in the division and New York is 37-31, so if Baltimore wins one more game, it will have home-field advantage if there's a playoff to decide the AL East title.

"The pressure's on both of us," Reynolds said. "Four games left, dead heat. I guess there's a possibility of two playoff games. It's what we play for, and it's fun."

In addition to hitting two homers and limiting Boston to five hits, Baltimore also played well defensively. Machado, the third baseman, ranged far to his right in the fourth inning to start a double play, and Reynolds tumbled over the tarp roll and got wedged behind it after catching a foul pop. Endy Chavez, who entered as a defensive replacement in the ninth, made a sparking diving catch of a sinking liner to right field.

"They just keeping doing what they have to do," Red Sox manager Bobby Valentine said of the Orioles. "Buck knows what he's doing. He puts in a defensive replacement and he makes a diving catch. They've done a great job with that young third baseman. He beat us tonight. He played excellent defense all year."

Jarrod Saltalamacchia homered for the Red Sox, who fell into last place with their 15th loss in 21 games. Boston has not finished in the cellar since 1992.

Doubront allowed four runs, three earned, and seven hits in seven innings. He struck out 10, walked one and hit a batter.

Red Sox leadoff hitter Jacoby Ellsbury went 1 for 4 after being sidelined since Sept. 20 with an unspecified injury. Ellsbury has only four homers and 26 RBIs after finishing second in AL MVP voting last season.

"I didn't see him play that way this year," Valentine said before the game. "He did not quite hit his stride this year."

Orioles rookie Steve Johnson took a three-hitter and a 3-2 lead into the sixth inning but was lifted after giving up a single and a walk. Hunter got Dustin Pedroia to hit a force at second, but a run came home when Cody Ross hit a sacrifice fly to right field that Davis dropped after Adam Jones drifted over from center and called for the ball. Hunter avoided further damage by getting Mauro Gomez to bounce into a double play.

Baltimore went up 1-0 in the second when Machado singled in a run after Doubront hit Davis with a pitch and Reynolds reached on a slow roller to third.

In the fourth, after Jones reached on a throwing error by shortstop Mike Aviles, Davis drove a 1-0 pitch far over the right-field wall for a 3-0 lead.

Saltalamacchia hit his 25th homer in the fifth after Gomez drew a leadoff walk.

NOTES: The Robinson statue stands alongside the team's five other Hall of Fame members, all of whom were in attendance: Earl Weaver, Frank Robinson, Jim Palmer, Eddie Murray and Cal Ripken Jr. ... Joe Saunders will pitch for the Orioles in the series finale Sunday. Zach Stewart will pitch for Boston. ... Baltimore claimed OF Steve Pearce off waivers from the Yankees. He will join the team in Tampa Bay on Monday. ... Boston has lost 17 of 24 to Baltimore since September 2011.

Source: http://news.yahoo.com/orioles-beat-boston-gain-tie-al-east-lead-020501937--mlb.html

lotto numbers susan powell megamillions winners university of louisville louisville ky final four lotto winners

EKNL - Penny Stocks Investing

The BUZZZ this weekend is insane and word on the street is that theres are several MAJOR updates that will be unleashed this week to breakout EKNL in solid ?core? pick fashion.

EKNL IS?OUR MONSTER 2012 PICK TO?RIVAL DROPs $1.25 target (83,000% in gains)

As we have seen our 2011 monster Fuse Science (DROP) soar to hit our target of $1.25 (+83,000% gains) bang on soon after our special report was unleashed, EKNL?is on the right track to do the same

Definitely people are stoked after we raised our price targets in our Special Report this weekend and for very good reasons.

Get the SPECIAL report here and see what price target we now have on EKNL.

EKNL busted out of the gates last week soaring 200% since our alert at $0.04, and reveling several strategic initiatives - no doubt showing what was building over the past few months and much more to be seen.

EKNL announced a J.V. with NeuroVasc Clinical Inc.(NCI) to start distribution of FREMS in North America

EKNL just announced their first of many clinics that will be treating patients with their FREMS patented technology equipment. The Mayer Institute is world renowned for specializing in the treatment of Diabetics, and no doubt this is a HUGE score for EKNL and opens up the flood gates for many more clinics to be part of this FREMS technology ? we are sure we will be hearing much more details over the next few weeks.

EKNL is tightly held buy insiders and they are definitely not letting go of any shares at these super cheap prices, let alone anything under the dollar level.

EKNL only has 8 Million shares in the float and what we have also learned was that available for trading in the DTC is only 5.5 Million shares! This is insane and stock inventory is super thin making it more difficult each day to purchase any shares. We are already starting to see the effects of this super thin inventory.

EKO International Corp.

Make sure to read the special report released this weekend ? a must read for this weeks trading.

Special Report Article except: ?It is estimated that there are 60 million diabetics in North American in 2012 and that number is climbing rapidly. Approximately 65% of diabetics will develop peripheral neuropathy?

ABOUT EKO INTERNATIONAL

EKO International Corp. is a holding company focused on growth through acquisition. Each acquisition must have substantial growth potential and is expected to add assets and/or cash-flow to the consolidated financial statements of the Company. The Company? is willing to examine a variety of proposed target businesses and if interested, will negotiate terms and conditions of purchase favorable to itself.

Compensation: Ourhotstockpicks has not been compensated for the profile of EKNL.

Ourhotstockpicks.com profiles are not a solicitation or recommendation to buy, sell or hold securities and is not offering securities for sale.? An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. Ourhotstockpicks may be buyers of features in the open market. Click here to view the full disclaimer

?

from your own site.

Source: http://www.ourhotstockpicks.com/eknl-huge-buzz-on-the-street-leading-to-a-major-update-this-week/

daylight saving time 2012 grapes of wrath silent house nfl mock draft project m rubio colts